Co-option of retrotransposons promotes antibody diversification
Cell · 2026
DOI: 10.1016/j.cell.2026.07.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026. Verfasst von Max C Lauring und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, USA. Hauptthemen laut MEDLINE: Long Interspersed Nucleotide Elements, Antibody Diversity. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Activation-induced cytidine deaminase (AID) accomplishes somatic hypermutation (SHM) of VH(D)JH genes in germinal center B cells for antibody diversification and affinity maturation. How AID specifically targets VH(D)JH remains unclear. We report the discovery of LINE-1 (L1) retrotransposons upstream to many VH genes in the immunoglobulin locus. These L1s are evolutionarily old, truncated, and retrotransposition dead. Recombined VH promoters generate long, strong antisense RNAs encoding upstream L1s, triggering the human silencing hub (HUSH) complex and AID recruitment, which we term L1-driven SHM. We show that L1-driven SHM occurs in vivo using HUSH conditional knockout mice and engineered mice with VH genes devoid of upstream L1s. Insertion of transcriptionally active L1s at non-immunoglobulin loci endogenously lacking upstream L1s promotes off-target SHM. We demonstrate that old retrotransposons serve physiological roles, and our findings reveal how B cells co-opted an anti-retrotransposon silencing mechanism to promote antibody diversity. In doing so, we established a new link between cell-intrinsic innate and adaptive immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
- Division of Life Science, Department of Chemical and Biological Engineering and State Key Laboratory of Nervous System Disorders, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong S…
- Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA.
- Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.
- Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, USA. Electronic address: ub2121@cumc.columbia.edu.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- National Institutes of Health
- Columbia University
- National Institute of General Medical Sciences
- NIAID
Zitieren
APA
Lauring, M. C., Yang, M., Sarode, A., Wang, J., Ni, Z., Froehlich, K. A., Zhang, W., Wahed, S., Zheng, S., Goff, S. P., Wang, J., & Basu, U. (2026). Co-option of retrotransposons promotes antibody diversification. Cell. https://doi.org/10.1016/j.cell.2026.07.021
Vancouver
Lauring MC, Yang M, Sarode A, Wang J, Ni Z, Froehlich KA, et al. Co-option of retrotransposons promotes antibody diversification. Cell. 2026. doi:10.1016/j.cell.2026.07.021
BibTeX
@article{Lauring2026,
author = {Lauring, Max C and Yang, Ming and Sarode, Aditya and Wang, Jianhua and Ni, Zixin and Froehlich, Kristen A and Zhang, Wanwei and Wahed, Shudipto and Zheng, Sisi and Goff, Stephen P and Wang, Jiguang and Basu, Uttiya},
title = {Co-option of retrotransposons promotes antibody diversification},
journal = {Cell},
year = {2026},
doi = {10.1016/j.cell.2026.07.021}
}
EUVIMED